Nisa Investment Advisors, LLC Cue Biopharma, Inc. Transaction History

Nisa Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$1.72 - $3.1 $34 - $62	20 New	20 $0
Q1 2022 Apr 29, 2022	SELL	$4.41 - $12.28 $13,318 - $37,085	-3,020 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$10.86 - $17.85 $20,959 - $34,450	-1,930 Reduced 38.99%	3,020 $22,000
Q3 2021 Oct 18, 2021	SELL	$10.06 - $15.3 $5,030 - $7,650	-500 Reduced 9.17%	4,950 $72,000
Q2 2021 Aug 06, 2021	BUY	$10.9 - $14.53 $53,955 - $71,923	4,950 Added 990.0%	5,450 $63,000
Q1 2021 Apr 26, 2021	SELL	$11.2 - $16.09 $5,600 - $8,045	-500 Reduced 50.0%	500 $6,000
Q4 2020 Jan 25, 2021	BUY	$11.12 - $16.4 $11,120 - $16,400	1,000 New	1,000 $13,000

11.9M

22K

1.2K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $33.6M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.